China Gateway Life Science

China Gateway Life Science was a specialty pharmaceutical services organization that facilitated the entry of Western biotechnology and pharmaceutical companies into the Chinese market. The company provided a comprehensive suite of services, including regulatory affairs, clinical trial management, and business development. By leveraging local expertise, it helped international clients navigate the complex CFDA regulatory landscape. In 2008, the firm was acquired by Aptuit, a move that significantly expanded Aptuit's global drug development capabilities into Asia. Today, its former operations are integrated into the broader service offerings of Evotec following subsequent mergers. The company played a key role in bridging the gap between international drug development standards and the emerging Chinese healthcare sector.